Sheng Jiang

1.7k total citations
58 papers, 1.4k citations indexed

About

Sheng Jiang is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Sheng Jiang has authored 58 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 24 papers in Molecular Biology and 17 papers in Organic Chemistry. Recurrent topics in Sheng Jiang's work include CAR-T cell therapy research (14 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Peptidase Inhibition and Analysis (5 papers). Sheng Jiang is often cited by papers focused on CAR-T cell therapy research (14 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Peptidase Inhibition and Analysis (5 papers). Sheng Jiang collaborates with scholars based in China, United States and Hong Kong. Sheng Jiang's co-authors include Kuojun Zhang, Xiaoxing Wu, Tianyu Wang, Zheng Li, Xiangyu Zhang, Kun Ma, Haiping Hao, Wanheng Zhang, Qicai Xiao and Yibei Xiao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and PLoS ONE.

In The Last Decade

Sheng Jiang

55 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheng Jiang China 20 508 456 338 176 166 58 1.4k
Vinodh Kannappan United Kingdom 17 552 1.1× 360 0.8× 88 0.3× 314 1.8× 103 0.6× 23 1.7k
Jiaxuan Qiu China 15 483 1.0× 213 0.5× 83 0.2× 143 0.8× 46 0.3× 31 966
Bo Cao China 20 747 1.5× 277 0.6× 69 0.2× 95 0.5× 59 0.4× 40 1.3k
Wenying Yu China 25 816 1.6× 482 1.1× 283 0.8× 90 0.5× 268 1.6× 80 2.0k
Xinlai Cheng Germany 25 681 1.3× 329 0.7× 356 1.1× 197 1.1× 91 0.5× 57 1.4k
Yao Dai United States 20 758 1.5× 300 0.7× 52 0.2× 37 0.2× 130 0.8× 49 1.3k
Shuangping Liu China 23 969 1.9× 234 0.5× 153 0.5× 256 1.5× 93 0.6× 62 1.7k
Shuhong Wu China 27 1.1k 2.1× 499 1.1× 343 1.0× 62 0.4× 162 1.0× 81 1.9k

Countries citing papers authored by Sheng Jiang

Since Specialization
Citations

This map shows the geographic impact of Sheng Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng Jiang more than expected).

Fields of papers citing papers by Sheng Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheng Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng Jiang. The network helps show where Sheng Jiang may publish in the future.

Co-authorship network of co-authors of Sheng Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Sheng Jiang. A scholar is included among the top collaborators of Sheng Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng Jiang. Sheng Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Yao, Kaizhen Wang, Xiang Ni, et al.. (2025). Discovery, Synthesis, and Activity Evaluation of Novel Small-Molecule Inhibitors Targeting VISTA for Cancer Immunotherapy. Journal of Medicinal Chemistry. 68(5). 5222–5237. 1 indexed citations
2.
Mao, Jie, Yuxing Wu, Kaizhen Wang, et al.. (2025). Discovery of 1,2,4-benzotriazine derivatives as new hematopoietic progenitor kinase 1 (HPK1) inhibitors. Bioorganic Chemistry. 156. 108158–108158. 2 indexed citations
3.
Wang, Kaizhen, Xiang Ni, Sheng Jiang, et al.. (2024). Discovery of small molecules for autophagy-lysosome degradation of immune checkpoint proteins. European Journal of Medicinal Chemistry. 280. 116958–116958. 1 indexed citations
4.
Wang, Kaizhen, Xiangyu Zhang, Yingxin Hu, et al.. (2024). Discovery of novel phenyl urea SHP2 inhibitors with anti-colon cancer and potential immunomodulatory effects. European Journal of Medicinal Chemistry. 281. 117036–117036. 2 indexed citations
5.
Wang, Kaizhen, Hongtao Shen, Tianyu Wang, et al.. (2023). Discovery of diaminotriazine carboxamides as potent inhibitors of hematopoetic progenitor kinase 1. Bioorganic Chemistry. 138. 106682–106682. 5 indexed citations
6.
Wang, Kaizhen, Ke Ye, Xinyuan Zhou, et al.. (2023). Design, synthesis, and evaluation of PD-1/PD-L1 small-molecule inhibitors bearing a rigid indane scaffold. European Journal of Medicinal Chemistry. 256. 115468–115468. 15 indexed citations
7.
Tang, He, Lin Wang, Tianyu Wang, et al.. (2023). Recent advances of targeting nicotinamide phosphoribosyltransferase (NAMPT) for cancer drug discovery. European Journal of Medicinal Chemistry. 258. 115607–115607. 19 indexed citations
8.
Zhang, Kuojun, Tianyu Wang, Maotian Li, et al.. (2023). Discovery of quinazolin-4-one-based non-covalent inhibitors targeting the severe acute respiratory syndrome coronavirus 2 main protease (SARS-CoV-2 Mpro). European Journal of Medicinal Chemistry. 257. 115487–115487. 14 indexed citations
9.
Wang, Tianyu, et al.. (2022). The development of small-molecule inhibitors targeting HPK1. European Journal of Medicinal Chemistry. 244. 114819–114819. 37 indexed citations
10.
Wu, Lichuan, Ke Ye, Sheng Jiang, & Guang‐Biao Zhou. (2021). Marine Power on Cancer: Drugs, Lead Compounds, and Mechanisms. Marine Drugs. 19(9). 488–488. 22 indexed citations
11.
Ni, Yong, et al.. (2021). Synthesis and evaluation of enantiomers of hydroxychloroquine against SARS-CoV-2 in vitro. Bioorganic & Medicinal Chemistry. 53. 116523–116523. 12 indexed citations
12.
Xiao, Qicai, Huirong Lin, Juan Wu, et al.. (2020). Pyridine-Embedded Phenothiazinium Dyes as Lysosome-Targeted Photosensitizers for Highly Efficient Photodynamic Antitumor Therapy. Journal of Medicinal Chemistry. 63(9). 4896–4907. 56 indexed citations
13.
Zhang, Wanheng, Kuojun Zhang, Yiwu Yao, et al.. (2020). Dual nicotinamide phosphoribosyltransferase and epidermal growth factor receptor inhibitors for the treatment of cancer. European Journal of Medicinal Chemistry. 211. 113022–113022. 15 indexed citations
14.
Wang, Sixian, Xu Jiang, Sheng Jiang, et al.. (2020). Generation of human induced pluripotent stem cell line (WMUi001-A) from a patient with aortic dissection. Stem Cell Research. 43. 101730–101730. 4 indexed citations
15.
Miao, Qi, Kun Ma, Dong Chen, Xiaoxing Wu, & Sheng Jiang. (2019). Targeting tropomyosin receptor kinase for cancer therapy. European Journal of Medicinal Chemistry. 175. 129–148. 21 indexed citations
16.
Zhang, Kuojun, Yong Ni, Jiaxuan Chen, et al.. (2019). Discovery of trans-3-(pyridin-3-yl)acrylamide-derived sulfamides as potent nicotinamide phosphoribosyltransferase (NAMPT) inhibitors for the potential treatment of cancer. Bioorganic & Medicinal Chemistry Letters. 29(12). 1502–1506. 16 indexed citations
17.
Yang, Zhen, Sheng Jiang, Yatao Qiu, et al.. (2019). Single‐Molecule Force Measurement Guides the Design of Multivalent Ligands with Picomolar Affinity. Angewandte Chemie International Edition. 58(16). 5272–5276. 13 indexed citations
18.
Wang, Tianyu, Jichao Chen, Jia Wang, et al.. (2018). Cobalt-catalyzed carbon–sulfur/selenium bond formation: synthesis of benzo[b]thio/selenophene-fused imidazo[1,2-a]pyridines. Organic & Biomolecular Chemistry. 16(20). 3721–3725. 23 indexed citations
19.
Gutowski, Timothy G., Sheng Jiang, Daniel Cooper, et al.. (2017). Note on the Rate and Energy Efficiency Limits for Additive Manufacturing. Journal of Industrial Ecology. 21(S1). 122 indexed citations
20.
Xiao, Qicai, Yongqiang Liu, Yatao Qiu, et al.. (2011). Design, synthesis of symmetrical bivalent mimetics of annonaceous acetogenins and their cytotoxicities. Bioorganic & Medicinal Chemistry Letters. 21(12). 3613–3615. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vinodh Kannappan Breakdown of academic impact, for papers by Jiaxuan Qiu Breakdown of academic impact, for papers by Bo Cao Breakdown of academic impact, for papers by Wenying Yu Breakdown of academic impact, for papers by Xinlai Cheng Breakdown of academic impact, for papers by Yao Dai Breakdown of academic impact, for papers by Shuangping Liu Breakdown of academic impact, for papers by Shuhong Wu
Rankless by CCL
2026